Human medicines European public assessment report (EPAR): Genvoya, elvitegravir,cobicistat,emtricitabine,tenofovir alafenamide, Date of authorisation: 19/11/2015, Revision: 28, Status: Authorised

Human medicines European public assessment report (EPAR): Genvoya, elvitegravir,cobicistat,emtricitabine,tenofovir alafenamide, Date of authorisation: 19/11/2015, Revision: 28, Status: Authorised

Human medicines European public assessment report (EPAR): Vpriv, velaglucerase alfa, Date of authorisation: 26/08/2010, Revision: 21, Status: Authorised

Human medicines European public assessment report (EPAR): Vpriv, velaglucerase alfa, Date of authorisation: 26/08/2010, Revision: 21, Status: Authorised

Human medicines European public assessment report (EPAR): Jaypirca, pirtobrutinib, Date of authorisation: 30/10/2023, Revision: 4, Status: Authorised

Human medicines European public assessment report (EPAR): Jaypirca, pirtobrutinib, Date of authorisation: 30/10/2023, Revision: 4, Status: Authorised

Human medicines European public assessment report (EPAR): Tadalafil Lilly, tadalafil, Date of authorisation: 22/03/2017, Revision: 8, Status: Authorised

Human medicines European public assessment report (EPAR): Tadalafil Lilly, tadalafil, Date of authorisation: 22/03/2017, Revision: 8, Status: Authorised

Human medicines European public assessment report (EPAR): Cialis, tadalafil, Date of authorisation: 12/11/2002, Revision: 34, Status: Authorised

Human medicines European public assessment report (EPAR): Cialis, tadalafil, Date of authorisation: 12/11/2002, Revision: 34, Status: Authorised

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

randomness